Cargando…

Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain

Enteric fever is caused by three Salmonella enterica serovars: Typhi, Paratyphi A, and Paratyphi B sensu stricto. Although vaccines against two of these serovars are licensed (Typhi) or in clinical development (Paratyphi A), as yet there are no candidates for S. Paratyphi B. To gain genomic insight...

Descripción completa

Detalles Bibliográficos
Autores principales: Higginson, Ellen E., Ramachandran, Girish, Hazen, Tracy H., Kania, Dane A., Rasko, David A., Pasetti, Marcela F., Levine, Myron M., Tennant, Sharon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262260/
https://www.ncbi.nlm.nih.gov/pubmed/30487152
http://dx.doi.org/10.1128/mSphere.00474-18
_version_ 1783375066011009024
author Higginson, Ellen E.
Ramachandran, Girish
Hazen, Tracy H.
Kania, Dane A.
Rasko, David A.
Pasetti, Marcela F.
Levine, Myron M.
Tennant, Sharon M.
author_facet Higginson, Ellen E.
Ramachandran, Girish
Hazen, Tracy H.
Kania, Dane A.
Rasko, David A.
Pasetti, Marcela F.
Levine, Myron M.
Tennant, Sharon M.
author_sort Higginson, Ellen E.
collection PubMed
description Enteric fever is caused by three Salmonella enterica serovars: Typhi, Paratyphi A, and Paratyphi B sensu stricto. Although vaccines against two of these serovars are licensed (Typhi) or in clinical development (Paratyphi A), as yet there are no candidates for S. Paratyphi B. To gain genomic insight into these serovars, we sequenced 38 enteric fever-associated strains from Chile and compared these with reference genomes. Each of the serovars was separated genomically based on the core genome. Genomic comparisons identified loci that were aberrant between serovars Paratyphi B sensu stricto and Paratyphi B Java, which is typically associated with gastroenteritis; however, the majority of these were annotated as hypothetical or phage related and thus were not ideal vaccine candidates. With the genomic information in hand, we engineered a live attenuated S. Paratyphi B sensu stricto vaccine strain, CVD 2005, which was capable of protecting mice from both homologous challenge and heterologous challenge with S. Paratyphi B Java. These findings extend our understanding of S. Paratyphi B and provide a viable vaccine option for inclusion in a trivalent live attenuated enteric fever vaccine formulation. IMPORTANCE We developed a live attenuated Salmonella enterica serovar Paratyphi B vaccine that conferred protection in mice against challenge with S. Paratyphi B sensu stricto and S. Paratyphi B Java, which are the causes of enteric fever and gastroenteritis, respectively. Currently, the incidence of invasive S. Paratyphi B sensu stricto infections is low; however, the development of new conjugate vaccines against other enteric fever serovars could lead to the emergence of S. Paratyphi B to fill the niche left by these other pathogens. As such, an effective S. Paratyphi B vaccine would be a useful tool in the armamentarium against Salmonella infections. Comparative genomics confirmed the serovar-specific groupings of these isolates and revealed that there are a limited number of genetic differences between the sensu stricto and Java strains, which are mostly hypothetical and phage-encoded proteins. The observed level of genomic similarity likely explains why we observe some cross-protection.
format Online
Article
Text
id pubmed-6262260
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-62622602018-11-30 Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain Higginson, Ellen E. Ramachandran, Girish Hazen, Tracy H. Kania, Dane A. Rasko, David A. Pasetti, Marcela F. Levine, Myron M. Tennant, Sharon M. mSphere Research Article Enteric fever is caused by three Salmonella enterica serovars: Typhi, Paratyphi A, and Paratyphi B sensu stricto. Although vaccines against two of these serovars are licensed (Typhi) or in clinical development (Paratyphi A), as yet there are no candidates for S. Paratyphi B. To gain genomic insight into these serovars, we sequenced 38 enteric fever-associated strains from Chile and compared these with reference genomes. Each of the serovars was separated genomically based on the core genome. Genomic comparisons identified loci that were aberrant between serovars Paratyphi B sensu stricto and Paratyphi B Java, which is typically associated with gastroenteritis; however, the majority of these were annotated as hypothetical or phage related and thus were not ideal vaccine candidates. With the genomic information in hand, we engineered a live attenuated S. Paratyphi B sensu stricto vaccine strain, CVD 2005, which was capable of protecting mice from both homologous challenge and heterologous challenge with S. Paratyphi B Java. These findings extend our understanding of S. Paratyphi B and provide a viable vaccine option for inclusion in a trivalent live attenuated enteric fever vaccine formulation. IMPORTANCE We developed a live attenuated Salmonella enterica serovar Paratyphi B vaccine that conferred protection in mice against challenge with S. Paratyphi B sensu stricto and S. Paratyphi B Java, which are the causes of enteric fever and gastroenteritis, respectively. Currently, the incidence of invasive S. Paratyphi B sensu stricto infections is low; however, the development of new conjugate vaccines against other enteric fever serovars could lead to the emergence of S. Paratyphi B to fill the niche left by these other pathogens. As such, an effective S. Paratyphi B vaccine would be a useful tool in the armamentarium against Salmonella infections. Comparative genomics confirmed the serovar-specific groupings of these isolates and revealed that there are a limited number of genetic differences between the sensu stricto and Java strains, which are mostly hypothetical and phage-encoded proteins. The observed level of genomic similarity likely explains why we observe some cross-protection. American Society for Microbiology 2018-11-28 /pmc/articles/PMC6262260/ /pubmed/30487152 http://dx.doi.org/10.1128/mSphere.00474-18 Text en Copyright © 2018 Higginson et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Higginson, Ellen E.
Ramachandran, Girish
Hazen, Tracy H.
Kania, Dane A.
Rasko, David A.
Pasetti, Marcela F.
Levine, Myron M.
Tennant, Sharon M.
Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain
title Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain
title_full Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain
title_fullStr Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain
title_full_unstemmed Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain
title_short Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain
title_sort improving our understanding of salmonella enterica serovar paratyphi b through the engineering and testing of a live attenuated vaccine strain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262260/
https://www.ncbi.nlm.nih.gov/pubmed/30487152
http://dx.doi.org/10.1128/mSphere.00474-18
work_keys_str_mv AT higginsonellene improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT ramachandrangirish improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT hazentracyh improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT kaniadanea improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT raskodavida improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT pasettimarcelaf improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT levinemyronm improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain
AT tennantsharonm improvingourunderstandingofsalmonellaentericaserovarparatyphibthroughtheengineeringandtestingofaliveattenuatedvaccinestrain